KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment.

MLA

Ruiz-Iruela, Cristina, et al. “KIF6 Gene as a Pharmacogenetic Marker for Lipid-Lowering Effect in Statin Treatment.” PLoS ONE, vol. 13, no. 10, Oct. 2018, pp. 1–14. EBSCOhost, https://doi.org/10.1371/journal.pone.0205430.

APA

Ruiz-Iruela, C., Padró-Miquel, A., Pintó-Sala, X., Baena-Díez, N., Caixàs-Pedragós, A., Güell-Miró, R., Navarro-Badal, R., Jusmet-Miguel, X., Calmarza, P., Puzo-Foncilla, J. L., Alía-Ramos, P., & Candás-Estébanez, B. (2018). KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment. PLoS ONE, 13(10), 1–14. https://doi.org/10.1371/journal.pone.0205430

Chicago

Ruiz-Iruela, Cristina, Ariadna Padró-Miquel, Xavier Pintó-Sala, Neus Baena-Díez, Assumpta Caixàs-Pedragós, Roser Güell-Miró, Rosa Navarro-Badal, et al. 2018. “KIF6 Gene as a Pharmacogenetic Marker for Lipid-Lowering Effect in Statin Treatment.” PLoS ONE 13 (10): 1–14. doi:10.1371/journal.pone.0205430.